Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Novo Nordisk Dividend Announcement
• Novo Nordisk announced a semi annually dividend of $0.08 per ordinary share which will be made payable on 2024-08-26. Ex dividend date: 2024-08-16
• Novo Nordisk annual dividend for 2024 was $0.21
• Novo Nordisk annual dividend for 2023 was $0.30
• Novo Nordisk's trailing twelve-month (TTM) dividend yield is 1.42%
• Novo Nordisk's payout ratio for the trailing twelve months (TTM) is 46.71%
• Novo Nordisk's dividend growth over the last five years (2018-2023) was 10.60% year
• Novo Nordisk's dividend growth over the last ten years (2013-2023) was -5.84% year
Novo Nordisk Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-08-16 | $0.08 | semi annually | 2024-08-26 |
2024-03-22 | $0.13 | semi annually | 2024-04-02 |
2023-08-18 | $0.13 | semi annually | 2023-08-29 |
2023-03-24 | $0.17 | semi annually | 2023-04-04 |
2022-08-12 | $0.08 | semi annually | 2022-08-23 |
2022-03-25 | $0.15 | semi annually | 2022-04-05 |
2021-08-16 | $0.09 | semi annually | 2021-08-25 |
2021-03-26 | $0.15 | semi annually | 2021-04-07 |
2020-08-14 | $0.08 | semi annually | 2020-08-25 |
2020-03-27 | $0.23 | semi annually | 2020-04-07 |
2019-08-16 | $0.07 | semi annually | 2019-08-27 |
2019-03-22 | $0.12 | semi annually | 2019-04-02 |
2018-08-17 | $0.07 | semi annually | 2018-08-28 |
2018-03-23 | $0.11 | semi annually | 2018-04-03 |
2017-08-17 | $0.07 | semi annually | 2017-08-29 |
2017-03-23 | $0.10 | semi annually | 2017-04-04 |
2016-08-11 | $0.07 | semi annually | 2016-08-23 |
2016-03-18 | $0.15 | semi annually | 2016-03-30 |
2015-03-19 | $0.11 | semi annually | 2015-03-31 |
2014-03-21 | $0.15 | semi annually | 2014-04-02 |
2013-03-21 | $0.55 | semi annually | 2013-04-02 |
Novo Nordisk Dividend per year
Novo Nordisk Dividend growth
Novo Nordisk Dividend Yield
Novo Nordisk current trailing twelve-month (TTM) dividend yield is 1.42%. Interested in purchasing Novo Nordisk stock? Use our calculator to estimate your expected dividend yield:
Novo Nordisk Financial Ratios
Novo Nordisk Dividend FAQ
Other factors to consider when evaluating Novo Nordisk as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Novo Nordisk stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Novo Nordisk's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Novo Nordisk publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Novo Nordisk distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Novo Nordisk are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Novo Nordisk sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Novo Nordisk distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Novo Nordisk declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Novo Nordisk's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Novo Nordisk's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.